| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150980 Cgrp analog |
| 06/23/2011 | US20110150979 Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types |
| 06/23/2011 | US20110150978 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same |
| 06/23/2011 | US20110150977 Antimicrobial polymers and methods of manufacture thereof |
| 06/23/2011 | US20110150976 Transdermal delivery of oligosaccharides |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150974 Agent For Oral Mucosal Administration |
| 06/23/2011 | US20110150973 Electrospun dextran fibers and devices formed therefrom |
| 06/23/2011 | US20110150972 Medical devices having improved performance |
| 06/23/2011 | US20110150971 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150970 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150969 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150968 Dissolvable dietary supplement strip and methods for using the same |
| 06/23/2011 | US20110150967 Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids |
| 06/23/2011 | US20110150963 Bioactive antibacterial bone graft materials |
| 06/23/2011 | US20110150962 Therapeutic agent capsule for implants |
| 06/23/2011 | US20110150954 Agent-encapsulating micro-and nanoparticles, methods for preparation of same and products containing same |
| 06/23/2011 | US20110150953 Method for producing vesicle, vesicle obtained by the production method, and w/o/w emulsion for producing vesicle |
| 06/23/2011 | US20110150946 Transdermal Delivery of Apomorphine Using Microneedles |
| 06/23/2011 | US20110150945 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer |
| 06/23/2011 | US20110150944 Structured triglycerides and emulsions comprising same |
| 06/23/2011 | US20110150943 Adhesive for medical applications and means for haemostasis |
| 06/23/2011 | US20110150942 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 06/23/2011 | US20110150941 Epithelial delivery |
| 06/23/2011 | US20110150940 Dry powder compositions and systems for poultry vaccination |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
| 06/23/2011 | US20110150937 Extended release compositions comprising tolterodine |
| 06/23/2011 | US20110150927 Stabilisation of Viral Microparticles |
| 06/23/2011 | US20110150785 Light Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 06/23/2011 | US20110150783 Aerosol formulation for copd |
| 06/23/2011 | US20110150782 Combination therapy for copd |
| 06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150766 Transdermal patch with fatal overdose protection |
| 06/23/2011 | US20110146677 Aerosol formulation for copd |
| 06/23/2011 | CA2784847A1 Injectable polymer composition for use as a cell delivery vehicle |
| 06/23/2011 | CA2784827A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | CA2784826A1 Methods and compositions for stable liquid drug formulations |
| 06/23/2011 | CA2784714A1 Liquid food composition |
| 06/23/2011 | CA2784712A1 Percutaneous absorption preparation comprising anti-dementia drug |
| 06/23/2011 | CA2784689A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | CA2784529A1 Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 06/23/2011 | CA2784235A1 Granules for pharmaceutical preparations, methods and apparatus for their production |
| 06/23/2011 | CA2784207A1 Antibiotic microparticles for inhalation |
| 06/23/2011 | CA2784145A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | CA2784142A1 Ophthalmic solutions with improved disinfection profiles |
| 06/23/2011 | CA2784133A1 Felbinac-containing transdermally absorbable preparation |
| 06/23/2011 | CA2784015A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | CA2783964A1 Piroxicam-containing transdermally absorbable preparation |
| 06/23/2011 | CA2783892A1 Modulator |
| 06/23/2011 | CA2783891A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | CA2783569A1 Transdermally absorbable preparation containing basic anti-inflammatory analgesic |
| 06/23/2011 | CA2783366A1 Uniform field magnetization and targeting of therapeutic formulations |
| 06/23/2011 | CA2783296A1 Growth hormone composition |
| 06/23/2011 | CA2782967A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | CA2782569A1 Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity |
| 06/23/2011 | CA2781999A1 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome |
| 06/23/2011 | CA2781199A1 Suppository comprising pantoprazole |
| 06/22/2011 | EP2336218A1 Hydrophilic material, medical material and sustained release pharmaceutical material |
| 06/22/2011 | EP2336086A1 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 06/22/2011 | EP2336066A2 Coil for rolling up a coated sheet of film |
| 06/22/2011 | EP2335705A1 Use of sphingomyelin for the treatment of influenza |
| 06/22/2011 | EP2335698A1 Pharmaceutical solid preparation having active ingredients separated by boundary therein |
| 06/22/2011 | EP2335697A1 Stable pharmaceutical formulation with limited discoloration |
| 06/22/2011 | EP2335696A1 An entacapone-containing oral dosage form |
| 06/22/2011 | EP2335694A1 Thyroid hormone analogs and methods of use. |
| 06/22/2011 | EP2335691A1 Formulations comprising vardenafil with controlled release of active ingredient |
| 06/22/2011 | EP2335690A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/22/2011 | EP2335689A1 Method of manufacturing nucleic acid micropheres |
| 06/22/2011 | EP2335688A1 Pharmaceutical compositions comprising sigma receptor ligands |
| 06/22/2011 | EP2335687A2 Use of monoolein as a new auxiliary lipid in lipofection |
| 06/22/2011 | EP2335686A1 An aqueous intravenous nanosuspension with reduced adverse effects |
| 06/22/2011 | EP2335628A1 Therapeutic agent capsule for implants |
| 06/22/2011 | EP2334396A1 Methods of processing microparticles |
| 06/22/2011 | EP2334394A1 Methods of processing compositions containing microparticles |
| 06/22/2011 | EP2334369A2 Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process |
| 06/22/2011 | EP2334311A2 Non-typeable haemophilus influenzae vaccines and their uses |
| 06/22/2011 | EP2334302A2 Dosage forms for weakly ionizable compounds |
| 06/22/2011 | EP2334291A2 Compositions for percutaneous administration |
| 06/22/2011 | EP2334290A1 Drug delivery system for econazole, moxifloxacin, and rifampicin |
| 06/22/2011 | EP2334289A1 Controlled-release nimesulide composition |
| 06/22/2011 | EP2334288A1 Microencapsulation process with solvent and salt |
| 06/22/2011 | EP2334287A2 Hot-melt extrusion of modified release multi-particulates |
| 06/22/2011 | EP2334286A1 Low ph retinoid topical compositions |
| 06/22/2011 | EP2334285A1 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| 06/22/2011 | EP2334284A2 Compacted cinacalcet |
| 06/22/2011 | EP2334202A1 Tabletting of ervthritol |
| 06/22/2011 | EP2334176A1 Topical formulations for treatment of neuropathy |
| 06/22/2011 | EP2095825B1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 06/22/2011 | EP1888624B1 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 06/22/2011 | EP1587514B3 A rapid-acting pharmaceutical composition |
| 06/22/2011 | EP1341526B1 Pharmaceutical compositions for the oral delivery of calcitonin |
| 06/22/2011 | DE102009058769A1 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung Temperature-dependent activation of catalytic nucleic acids for controlled drug release |
| 06/22/2011 | DE102009056871A1 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben Vaccine adjuvants and to improved methods for the preparation thereof |
| 06/22/2011 | DE102009039117A1 Aroma-spray comprising an anesthesia mask held over mouth and nose, to make oxygen, for each patient receiving a general anesthetic, where the mask is wetted with the aroma spray |
| 06/22/2011 | CN1903364B Medicine composition containing inhibitor of angiotonase and phenoxy acid compounds |
| 06/22/2011 | CN1883537B Compound Chinese medicinal preparation for treating hypertension and hyperlipemia and preparation method thereof |
| 06/22/2011 | CN1882317B Amylaceous film-forming composition |
| 06/22/2011 | CN1874778B Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |